FFLCLAMLZCNQAB-WTGUEVBISA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | BxJK4IREQcF |
|---|---|
| InChI | InChI=1S/C26H30N2O2/c1-3-7-17(8-4-1)22-16-30-26-20-11-13-21(27(22)26)19-12-14-24-28(25(19)20)23(15-29-24)18-9-5-2-6-10-18/h1-10,19-26H,11-16H2/t19-,20-,21+,22+,23+,24+,25-,26+/m1/s1 |
| InChIKey | FFLCLAMLZCNQAB-WTGUEVBISA-N |
| Mol Weight | 402.54 g/mol |
| Molecular Formula | C26H30N2O2 |
| Exact Mass | 402.230728 g/mol |
| Enantiomer InChIKey | FFLCLAMLZCNQAB-JDCVGWBSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
12-BETA-HYDROXYPREGNA-4,6-DIEN-3,20-DIONE
3-(benzylthio)-6-[(4-methylbenzyl)amino]-1,5-diphenyl-pyrazolo[3,4-d]pyrimidin-4-one
ethyl 2-({[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl}amino)-5-[(2-methoxyanilino)carbonyl]-4-methyl-3-thiophenecarboxylate
3-Azabicyclo[3.1.0]hex-2-ene-1,5-dicarbonitrile, 2-amino-4,4-dimethoxy-6-[4-(phenylmethoxy)phenyl]-
(8S,9S,11S,13S,14S)-2-fluoranyl-11-methoxy-13-methyl-3-oxidanyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
8-[benzyl(methyl)amino]-1-(2,4-dichlorobenzyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
18-HYDROXY-7-ALPHA,8-ALPHA-EPOXY-9-EPI-ENT-PIMARA-15-ENE
(4-BETAH)-(8-ALPHA)-(2-METHYLBUT-2-ENOYLOXY)-2-OXO-1(5),10(14),11(13)-GUAIATRIEN-12,6-ALPHA-OLIDE
3β-hydroxy-16β-methylpregn-5-en-20-one, acetate
2-Benzyl-3H-isoindol-1-one-3-spiro-2'-dihydrobenzocyclobutene
| Title | Journal or Book | Year |
|---|---|---|
| Preparation of a Novel Piperidine Structure Related to Nitrarine: A Biomimetic Model for the Asymmetric Synthesis of Nitraria Alkaloids | The Journal of Organic Chemistry | 1997 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.